Trang kết quả 13 cho Khu vực: Chăm sóc sức khỏe Ngành: Công nghệ sinh học Thị trường chứng khoán - Báo giá & giá
Danh sách tất cả các chứng khoán và vốn chủ sở hữu kèm giá, vốn hoá thị trường, PE và EPS
Tất cả các quốc gia
- {{country.name}}
- Tất cả các quốc gia
- Hoa Kỳ (1011)
- Úc (58)
- Áo (16)
- Bỉ (7)
- Brazil (16)
- Canada (83)
- Trung Quốc (94)
- Đan Mạch (6)
- Phần Lan (4)
- Pháp (41)
- Đức (737)
- Hồng Kông (46)
- Ấn Độ (19)
- Ai-len (1)
- Israel (19)
- Ý (4)
- Nhật Bản (37)
- Mexico (28)
- Hà Lan (3)
- New Zealand (1)
- Na Uy (14)
- Ba Lan (9)
- Nga (2)
- Hàn Quốc (10)
- Tây Ban Nha (4)
- Thụy Điển (70)
- Thụy Sĩ (11)
- Đài Loan (67)
- Thái Lan (2)
- Thổ Nhĩ Kỳ (1)
- Vương quốc Anh (69)
Tất cả các sàn giao dịch
- {{item.name}}
- Tất cả các sàn giao dịch
- Amsterdam (3)
- ASX (58)
- Brussels (7)
- BSE (9)
- Canadian Sec (30)
- Cboe CA (4)
- Copenhagen (6)
- Dusseldorf (1)
- Frankfurt (648)
- Helsinki (4)
- HKSE (46)
- IOB (25)
- Irish (1)
- Istanbul (1)
- KSE (10)
- LSE (44)
- MCE (4)
- MCX (2)
- Mexico (28)
- Milan (4)
- Munich (27)
- NasdaqCM (278)
- NasdaqGM (142)
- NasdaqGS (239)
- NSE (10)
- NYSE (10)
- NYSE American (20)
- NZSE (1)
- Oslo (14)
- Other OTC (322)
- Paris (41)
- São Paulo (16)
- Shanghai (47)
- Shenzhen (47)
- Stockholm (70)
- Stuttgart (38)
- Swiss (11)
- Taipei Exchange (59)
- Taiwan (8)
- Tel Aviv (19)
- Thailand (2)
- Tokyo (37)
- Toronto (19)
- TSXV (30)
- Vienna (16)
- Warsaw (9)
- XETRA (23)
Chăm sóc sức khỏe (2608)
- {{item.name}}
- Tất cả các khối
- Chăm sóc sức khỏe (2608)
Công nghệ sinh học (2608)
- {{item.name}}
- Tất cả các ngành
- Công nghệ sinh học (2608)
- Nhà sản xuất thuốc - Chung (279)
- Nhà sản xuất thuốc - Biệt dược & Thuốc gốc (1702)
- Gói y tế (57)
- Cơ sơ chăm sóc y tế (554)
- Nhà bán lẻ thuốc (155)
- Dịch vụ thông tin sức khỏe (420)
- Thiết bị y tế (913)
- Thiết bị & nguồn cung y tế (502)
- Chẩn đoán & nghiên cứu (427)
- Phân phối y tế (138)
| Tên Tên | Giá Giá |
% 24h Biểu đồ 7n 24h% & 7n |
Vốn hoá TT Vốn hóa thị trường | KH. LƯỢNG Khối lượng | Đáy 24h | Đỉnh 24h | Vốn hóa thị trường | Tỉ lệ P/E | EPS |
|---|
| Tên Tên | Giá Giá |
% 24h Biểu đồ 7n 24h% & 7n |
Vốn hoá TT Vốn hóa thị trường | KH. LƯỢNG Khối lượng | Đáy 24h | Đỉnh 24h | Vốn hóa thị trường | Tỉ lệ P/E | EPS | |
|---|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} | |
| Cytokinetics, Incorporated KK3A.F | $55 60.12 USD |
+2.8
|
$6.03B 6.59B USD | $200 218.63 USD | $55 60.12 USD | $55 60.12 USD | $6.03B 6.59B USD | 0 | -$4.99 -5.4 USD | |
| ALK-Abelló A/S AKBLF | $22.45 — |
0
|
$6.24B — | $19 — | $22.45 — | $22.45 — | $6.24B — | 59.07 | $0.38 — | |
| Exelixis, Inc. EX9.F | $19.23 21.02 USD |
+0.16
|
$5.7B 6.23B USD | $47 51.38 USD | $19.23 21.02 USD | $19.23 21.02 USD | $5.7B 6.23B USD | 32.04 | $0.6 0.66 USD | |
| Halozyme Therapeutics, Inc. RV7.F | $41.96 45.87 USD |
+4.09
|
$5.61B 6.14B USD | $5 5.47 USD | $41.96 45.87 USD | $41.96 45.87 USD | $5.61B 6.14B USD | 18.81 | $2.23 2.44 USD | |
| Akeso, Inc. 4RY.F | $5.8 6.34 USD |
+4.5
|
$5.27B 5.76B USD | $351 383.69 USD | $5.8 6.34 USD | $5.8 6.34 USD | $5.27B 5.76B USD | 18.70 | $0.31 0.34 USD | |
| Ionis Pharmaceuticals, Inc. ISI.F | $34.99 38.25 USD |
-0.54
|
$5.26B 5.75B USD | $1.2K 1.31K USD | $34.99 38.25 USD | $36.22 39.59 USD | $5.26B 5.75B USD | 0 | -$2.47 -2.7 USD | |
| BridgeBio Pharma, Inc. 2CL.F | $27.49 30.05 USD |
+0.62
|
$5.22B 5.7B USD | $300 327.94 USD | $27.31 29.85 USD | $27.49 30.05 USD | $5.22B 5.7B USD | 0 | -$2.99 -3.2 USD | |
| Zealand Pharma A/S ZLDPF | $91.15 — |
-4.36
|
$5.68B — | $2.58K — | $89.61 — | $91.18 — | $5.68B — | 0 | -$1.8 — | |
| Abcam ABCM | $23.99 — |
0
|
$5.52B — | $0 — | $0 — | $0 — | $5.52B — | 0 | $0 — | |
| ImmunityBio, Inc. 26CA.F | $7.1 7.76 USD |
-3.77
|
$4.98B 5.45B USD | $1.32K 1.44K USD | $7.05 7.71 USD | $7.26 7.94 USD | $4.98B 5.45B USD | 0 | -$1 -1.09 USD | |
| SK Biopharmaceuticals Co., Ltd. 326030.KS | $89,600 67.63 USD |
+2.4
|
$7.02T 5.3B USD | $0 0 USD | $0 0 USD | $0 0 USD | $7.02T 5.3B USD | 0 | $0 0 USD | |
| Abcam plc A8C3.F | $11.7 12.79 USD |
0
|
$4.82B 5.27B USD | $0 0 USD | $0 0 USD | $0 0 USD | $4.82B 5.27B USD | 0 | $0 0 USD | |
| Halozyme Therapeutics, Inc. HALO.MX | $680 40.26 USD |
0
|
$86.55B 5.12B USD | $0 0 USD | $680 40.26 USD | $680 40.26 USD | $86.55B 5.12B USD | 21.27 | $31.96 1.89 USD | |
| Abcam ABCZF | $22.25 — |
0
|
$5.12B — | $4K — | $22.25 — | $22.25 — | $5.12B — | 2225.00 | $0.01 — | |
| Apellis Pharmaceuticals, Inc. 1JK.F | $38.44 42.01 USD |
-1.68
|
$4.66B 5.1B USD | $20 21.86 USD | $37.83 41.35 USD | $38.44 42.01 USD | $4.66B 5.1B USD | 0 | -$3.17 -3.4 USD | |
| ALK-Abelló A/S 4AJ0.F | $20.5 22.41 USD |
+0.79
|
$4.64B 5.07B USD | $2.16K 2.36K USD | $20.5 22.41 USD | $20.5 22.41 USD | $4.64B 5.07B USD | 58.57 | $0.35 0.38 USD | |
| Krystal Biotech, Inc. 4KB.F | $149.05 162.93 USD |
+1.78
|
$4.39B 4.79B USD | $7 7.65 USD | $149.05 162.93 USD | $149.05 162.93 USD | $4.39B 4.79B USD | 73.78 | $2.02 2.21 USD | |
| Laboratorios Farmaceuticos Rovi, S.A. 41L.F | $85.7 93.68 USD |
-0.46
|
$4.39B 4.79B USD | $400 437.25 USD | $85.7 93.68 USD | $85.7 93.68 USD | $4.39B 4.79B USD | 33.21 | $2.58 2.82 USD | |
| Financière de Tubize SA FTD.F | $95.1 103.96 USD |
+1.39
|
$4.33B 4.74B USD | $4 4.37 USD | $95.1 103.96 USD | $95.1 103.96 USD | $4.33B 4.74B USD | 48.03 | $1.98 2.16 USD | |
| Financière de Tubize SA FTD.SG | $95.9 104.83 USD |
+0.42
|
$4.29B 4.69B USD | $0 0 USD | $95.4 104.29 USD | $95.9 104.83 USD | $4.29B 4.69B USD | 48.43 | $1.98 2.16 USD | |
| Krystal Biotech, Inc. 4KB.SG | $149.25 163.15 USD |
-0.5
|
$4.29B 4.69B USD | $0 0 USD | $149.05 162.93 USD | $149.3 163.21 USD | $4.29B 4.69B USD | 74.25 | $2.01 2.2 USD | |
| Madrigal Pharmaceuticals, Inc. YDO1.F | $197.35 215.73 USD |
+2.1
|
$4.26B 4.66B USD | $10 10.93 USD | $192.3 210.21 USD | $197.35 215.73 USD | $4.26B 4.66B USD | 0 | -$21.39 -23.3 USD | |
| Alpine Immune Sciences, Inc. 34LA.F | $59 64.49 USD |
0
|
$4.12B 4.51B USD | $20 21.86 USD | $58.5 63.95 USD | $59 64.49 USD | $4.12B 4.51B USD | 0 | -$0.59 -0.6 USD | |
| ALK-Abelló A/S 0OIR.IL | $149.45 21.91 USD |
0
|
$30B 4.4B USD | $3.88K 568.45 USD | $154.4 22.64 USD | $155.7 22.83 USD | $30B 4.4B USD | 92.82 | $1.61 0.24 USD | |
| Mirati Therapeutics, Inc. 26M.F | $53.3 58.26 USD |
0
|
$3.79B 4.14B USD | $0 0 USD | $0 0 USD | $0 0 USD | $3.79B 4.14B USD | 0 | $0 0 USD | |
| Mirati Therapeutics MRTX | $58.7 — |
0
|
$4.12B — | $0 — | $0 — | $0 — | $4.12B — | 0 | $0 — | |
| Asymchem Laboratories (Tianjin) Co., Ltd. 7K90.F | $7.3 7.98 USD |
+0.69
|
$3.76B 4.11B USD | $56 61.22 USD | $7.3 7.98 USD | $7.3 7.98 USD | $3.76B 4.11B USD | 10.73 | $0.68 0.74 USD | |
| Crinetics Pharmaceuticals, Inc. 6Z4.F | $46.2 50.5 USD |
+1.76
|
$3.75B 4.1B USD | $40 43.73 USD | $46.2 50.5 USD | $46.2 50.5 USD | $3.75B 4.1B USD | 0 | -$3.49 -3.8 USD | |
| BB Biotech AG BB.MI | $65.2 71.27 USD |
0
|
$3.58B 3.91B USD | $10.08K 11.02K USD | $51.6 56.41 USD | $52.9 57.83 USD | $3.58B 3.91B USD | 5.75 | $11.32 12.37 USD | |
| CymaBay Therapeutics, Inc. C0I.F | $29.8 32.58 USD |
0
|
$3.43B 3.75B USD | $0 0 USD | $0 0 USD | $0 0 USD | $3.43B 3.75B USD | 0 | $0 0 USD | |
| Insmed Incorporated IM8N.SG | $23 25.14 USD |
-0.86
|
$3.42B 3.74B USD | $0 0 USD | $22.8 24.92 USD | $23 25.14 USD | $3.42B 3.74B USD | 0 | -$4.84 -5.2 USD | |
| Insmed Incorporated IM8N.F | $23 25.14 USD |
-1.71
|
$3.42B 3.74B USD | $25 27.33 USD | $23 25.14 USD | $23 25.14 USD | $3.42B 3.74B USD | 0 | -$4.84 -5.2 USD | |
| CymaBay Therapeutics CBAY | $32.48 — |
0
|
$3.73B — | $0 — | $0 — | $0 — | $3.73B — | 0 | $0 — | |
| Axsome Therapeutics, Inc. 19X.F | $68.94 75.36 USD |
-2.43
|
$3.27B 3.58B USD | $200 218.63 USD | $68.94 75.36 USD | $68.94 75.36 USD | $3.27B 3.58B USD | 0 | -$5.96 -6.5 USD | |
| SK bioscience Co.,Ltd. 302440.KS | $60,100 45.37 USD |
+1.18
|
$4.62T 3.49B USD | $0 0 USD | $0 0 USD | $0 0 USD | $4.62T 3.49B USD | 0 | $0 0 USD | |
| Genscript Biotech Corporation G51.F | $1.46 1.6 USD |
+1.39
|
$3.17B 3.46B USD | $900 983.82 USD | $1.46 1.6 USD | $1.46 1.6 USD | $3.17B 3.46B USD | 0 | -$0.04 -0.04 USD | |
| Ultragenyx Pharmaceutical Inc. UP0.F | $37.8 41.32 USD |
0
|
$3.16B 3.46B USD | $100 109.31 USD | $37.8 41.32 USD | $37.8 41.32 USD | $3.16B 3.46B USD | 0 | -$7.35 -8.03 USD | |
| Arrowhead Pharmaceuticals, Inc. HDP1.F | $22.85 24.98 USD |
+8.71
|
$3.13B 3.42B USD | $20 21.86 USD | $22.85 24.98 USD | $22.85 24.98 USD | $3.13B 3.42B USD | 0 | -$3.91 -4.2 USD | |
| Syngene International Limited SYNGENE.BO | $686.25 8.3 USD |
+1.93
|
$275.39B 3.33B USD | $13.03K 157.61 USD | $670.05 8.11 USD | $689.5 8.34 USD | $275.39B 3.33B USD | 54.20 | $12.66 0.15 USD | |
| IDEAYA Biosciences, Inc. 30J.F | $38.4 41.98 USD |
+1.05
|
$3B 3.28B USD | $420 459.12 USD | $38.4 41.98 USD | $38.4 41.98 USD | $3B 3.28B USD | 0 | -$1.85 -2.02 USD | |
| IDEAYA Biosciences, Inc. 30J.SG | $38 41.54 USD |
-1.04
|
$2.94B 3.21B USD | $0 0 USD | $37.8 41.32 USD | $38 41.54 USD | $2.94B 3.21B USD | 0 | -$1.85 -2.02 USD | |
| Galapagos NV GXE.DE | $44.47 48.61 USD |
0
|
$2.93B 3.2B USD | $1 1.09 USD | $44.18 48.29 USD | $44.47 48.61 USD | $2.93B 3.2B USD | 0 | -$1.92 -2.09 USD | |
| Denali Therapeutics Inc. 4DN.MU | $19.06 20.84 USD |
+5.04
|
$2.89B 3.16B USD | $74 80.89 USD | $19.06 20.84 USD | $19.06 20.84 USD | $2.89B 3.16B USD | 0 | -$0.87 -0.9 USD | |
| Denali Therapeutics Inc. 4DN.F | $18.96 20.73 USD |
+4.55
|
$2.88B 3.14B USD | $100 109.31 USD | $18.96 20.73 USD | $19.07 20.84 USD | $2.88B 3.14B USD | 0 | -$0.87 -0.9 USD | |
| Camurus AB (publ) 7CA.F | $48.62 53.15 USD |
+1.76
|
$2.84B 3.11B USD | $40 43.73 USD | $48.62 53.15 USD | $48.62 53.15 USD | $2.84B 3.11B USD | 75.96 | $0.64 0.7 USD | |
| VitaSpring Biomedical VSBC | $15 — |
0
|
$3.1B — | $200 — | $15 — | $15 — | $3.1B — | 0 | $0 — | |
| Xenon Pharmaceuticals Inc. XP0.F | $37 40.45 USD |
-1.07
|
$2.79B 3.05B USD | $20 21.86 USD | $37 40.45 USD | $37 40.45 USD | $2.79B 3.05B USD | 0 | -$2.52 -2.7 USD | |
| Iovance Biotherapeutics, Inc. 2LB.F | $9.81 10.73 USD |
-0.69
|
$2.75B 3B USD | $501 547.66 USD | $9.81 10.73 USD | $9.81 10.73 USD | $2.75B 3B USD | 0 | -$1.67 -1.8 USD | |
| Amicus Therapeutics, Inc. AM6.F | $8.85 9.67 USD |
+3.51
|
$2.74B 2.99B USD | $850 929.16 USD | $8.85 9.67 USD | $8.85 9.67 USD | $2.74B 2.99B USD | 0 | -$0.45 -0.4 USD | |
| Corcept Therapeutics Incorporated HTD.F | $25.26 27.61 USD |
+0.04
|
$2.68B 2.93B USD | $50 54.66 USD | $25.26 27.61 USD | $25.31 27.67 USD | $2.68B 2.93B USD | 26.04 | $0.97 1.06 USD | |
| MorphoSys AG MOR2.F | $17 18.58 USD |
+3.03
|
$2.64B 2.89B USD | $100 109.31 USD | $16.5 18.04 USD | $17 18.58 USD | $2.64B 2.89B USD | 0 | -$1.38 -1.5 USD | |
| Maravai LifeSciences Holdings, Inc. MAR.F | $10.2 11.15 USD |
+0.99
|
$2.63B 2.88B USD | $25 27.33 USD | $10.2 11.15 USD | $10.4 11.37 USD | $2.63B 2.88B USD | 0 | -$0.92 -1.005 USD | |
| MorphoSys AG MOR.F | $69.8 76.3 USD |
+2.8
|
$2.63B 2.88B USD | $3.38K 3.7K USD | $67.6 73.9 USD | $70.15 76.68 USD | $2.63B 2.88B USD | 0 | -$5.53 -6.04 USD | |
| MorphoSys AG MOR.VI | $69.35 75.81 USD |
+2.29
|
$2.62B 2.87B USD | $0 0 USD | $67.75 74.06 USD | $69.35 75.81 USD | $2.62B 2.87B USD | 0 | -$5.53 -6.04 USD | |
| MorphoSys AG MPSYF | $71.38 — |
0
|
$2.77B — | $79 — | $71.38 — | $71.38 — | $2.77B — | 0 | -$5.97 — | |
| Immunocore Holdings plc 6YG.MU | $50.5 55.2 USD |
-0.98
|
$2.53B 2.76B USD | $13 14.21 USD | $50.5 55.2 USD | $50.5 55.2 USD | $2.53B 2.76B USD | 0 | -$1.32 -1.4 USD | |
| TG Therapeutics, Inc. NKB2.F | $16.15 17.65 USD |
-1.94
|
$2.5B 2.73B USD | $215 235.02 USD | $16.15 17.65 USD | $16.15 17.65 USD | $2.5B 2.73B USD | 57.66 | $0.28 0.31 USD | |
| Celldex Therapeutics, Inc. TCE2.F | $36.4 39.79 USD |
+1.11
|
$2.48B 2.71B USD | $85 92.92 USD | $36.4 39.79 USD | $36.4 39.79 USD | $2.48B 2.71B USD | 0 | -$2.65 -2.8 USD | |
| Immunocore Holdings plc 6YG.F | $49.8 54.44 USD |
-2.35
|
$2.47B 2.7B USD | $100 109.31 USD | $49.8 54.44 USD | $50.5 55.2 USD | $2.47B 2.7B USD | 0 | -$1.32 -1.4 USD | |
| Merus N.V. 2GH.F | $41 44.82 USD |
+0.49
|
$2.47B 2.7B USD | $105 114.78 USD | $41 44.82 USD | $41 44.82 USD | $2.47B 2.7B USD | 0 | -$2.53 -2.7 USD | |
| BB Biotech AG Ord BBZA.F | $42.95 46.95 USD |
+0.94
|
$2.39B 2.61B USD | $2.69K 2.94K USD | $42.3 46.24 USD | $42.95 46.95 USD | $2.39B 2.61B USD | 0 | -$3.85 -4.2 USD | |
| ACADIA Pharmaceuticals Inc. DR6.F | $13.82 15.1 USD |
+0.99
|
$2.33B 2.55B USD | $260 284.22 USD | $13.82 15.1 USD | $13.82 15.1 USD | $2.33B 2.55B USD | 0 | $0 0 USD | |
| Intellia Therapeutics, Inc. 38I.F | $23.71 25.92 USD |
-2.27
|
$2.29B 2.5B USD | $240 262.35 USD | $23.71 25.92 USD | $23.71 25.92 USD | $2.29B 2.5B USD | 0 | -$4.97 -5.4 USD | |
| Vericel Corporation ATQP.F | $45 49.19 USD |
+1.35
|
$2.25B 2.46B USD | $10 10.93 USD | $45 49.19 USD | $45 49.19 USD | $2.25B 2.46B USD | 4500.00 | $0.01 0.01 USD | |
| Rhythm Pharmaceuticals, Inc. 1RV.F | $36 39.35 USD |
-5.26
|
$2.2B 2.4B USD | $50 54.66 USD | $36 39.35 USD | $36 39.35 USD | $2.2B 2.4B USD | 0 | -$4.28 -4.6 USD | |
| Geron Corporation GON.F | $3.54 3.87 USD |
+2.25
|
$2.19B 2.39B USD | $400 437.25 USD | $3.54 3.87 USD | $3.54 3.87 USD | $2.19B 2.39B USD | 0 | -$0.32 -0.3 USD | |
| BioArctic AB (publ) 0RV2.IL | $231.3 22.58 USD |
-2.94
|
$23.14B 2.26B USD | $4.41K 429.98 USD | $231.4 22.59 USD | $241.4 23.56 USD | $23.14B 2.26B USD | 75.34 | $3.07 0.3 USD | |
| BioArctic AB (publ) B9A.F | $20.08 21.95 USD |
+12.62
|
$2.03B 2.22B USD | $450 491.91 USD | $20.08 21.95 USD | $20.44 22.34 USD | $2.03B 2.22B USD | 91.27 | $0.22 0.24 USD | |
| Rocket Pharmaceuticals, Inc. 9IP1.F | $21.61 23.62 USD |
+0.7
|
$2B 2.19B USD | $120 131.18 USD | $21.61 23.62 USD | $21.61 23.62 USD | $2B 2.19B USD | 0 | -$2.64 -2.8 USD | |
| Bavarian Nordic A/S BV3.DE | $25.3 27.66 USD |
0
|
$1.99B 2.18B USD | $661 722.56 USD | $25 27.33 USD | $25.73 28.13 USD | $1.99B 2.18B USD | 45.17 | $0.56 0.61 USD | |
| Novavax, Inc. NVAX.MX | $237 14.03 USD |
+11.13
|
$35.58B 2.11B USD | $7.76K 459.49 USD | $202 11.96 USD | $242 14.33 USD | $35.58B 2.11B USD | 0 | -$51.39 -3.04 USD | |
| Agios Pharmaceuticals, Inc. 8AP.F | $32.2 35.2 USD |
+2.55
|
$1.89B 2.07B USD | $100 109.31 USD | $32.2 35.2 USD | $32.2 35.2 USD | $1.89B 2.07B USD | 0 | -$5.83 -6.3 USD | |
| Galapagos NV G1LP34.SA | $7.59 1.54 USD |
+1.34
|
$9.97B 2.02B USD | $154 31.21 USD | $7.59 1.54 USD | $7.67 1.55 USD | $9.97B 2.02B USD | 2.90 | $2.61 0.53 USD | |
| Catalyst Pharmaceuticals, Inc. CN2.F | $15.1 16.5 USD |
+1.04
|
$1.84B 2.01B USD | $2K 2.19K USD | $15.1 16.5 USD | $15.1 16.5 USD | $1.84B 2.01B USD | 29.02 | $0.52 0.57 USD | |
| 3SBio Inc. 83B.F | $0.7099 0.78 USD |
-2.07
|
$1.83B 2B USD | $1K 1.09K USD | $0.7099 0.78 USD | $0.7099 0.78 USD | $1.83B 2B USD | 8.87 | $0.08 0.09 USD | |
| Galapagos NV GXE.F | $27.12 29.65 USD |
+3.04
|
$1.83B 2B USD | $332 362.92 USD | $27.12 29.65 USD | $27.72 30.3 USD | $1.83B 2B USD | 57.70 | $0.47 0.51 USD | |
| Bavarian Nordic A/S BV3.F | $23.12 25.27 USD |
+2.17
|
$1.83B 2B USD | $501 547.66 USD | $23.07 25.22 USD | $23.27 25.44 USD | $1.83B 2B USD | 13.68 | $1.69 1.85 USD | |
| Zai Lab Limited 1ZL.F | $18.2 19.9 USD |
-6.67
|
$1.82B 1.99B USD | $75 81.99 USD | $18.2 19.9 USD | $18.2 19.9 USD | $1.82B 1.99B USD | 0 | -$3.24 -3.5 USD | |
| Galapagos NV GXEA.F | $25.6 27.98 USD |
+1.59
|
$1.8B 1.97B USD | $150 163.97 USD | $25.6 27.98 USD | $25.6 27.98 USD | $1.8B 1.97B USD | 54.46 | $0.47 0.51 USD | |
| Shanghai Haohai Biological Technology Co., Ltd. 5HB.F | $4.9 5.36 USD |
+0.41
|
$1.79B 1.96B USD | $300 327.94 USD | $4.9 5.36 USD | $4.9 5.36 USD | $1.79B 1.96B USD | 14.84 | $0.33 0.36 USD | |
| Bavarian Nordic A/S BVNRY | $8.38 — |
+1.32
|
$1.96B — | $1.34K — | $8.38 — | $8.43 — | $1.96B — | 13.72 | $0.61 — | |
| Galapagos NV GLPG.VI | $26.5 28.97 USD |
0
|
$1.77B 1.94B USD | $0 0 USD | $26.5 28.97 USD | $26.5 28.97 USD | $1.77B 1.94B USD | 56.38 | $0.47 0.51 USD | |
| Bavarian Nordic A/S BVNKF | $21.2 — |
0
|
$1.93B — | $1 — | $21.2 — | $21.2 — | $1.93B — | 11.64 | $1.82 — | |
| Syndax Pharmaceuticals, Inc. 1T3.F | $19.7 21.53 USD |
+0.51
|
$1.73B 1.89B USD | $100 109.31 USD | $19.7 21.53 USD | $19.7 21.53 USD | $1.73B 1.89B USD | 0 | -$3 -3.2 USD | |
| Veracyte, Inc. 12V.F | $21.4 23.39 USD |
+1.9
|
$1.7B 1.85B USD | $40 43.73 USD | $21.4 23.39 USD | $21.4 23.39 USD | $1.7B 1.85B USD | 0 | -$0.86 -0.9 USD | |
| Neuren Pharmaceuticals NURPF | $13.56 — |
0
|
$1.84B — | $1.76K — | $13.56 — | $13.56 — | $1.84B — | 17.16 | $0.79 — | |
| Ardelyx, Inc. 41X.F | $7.13 7.8 USD |
-1.22
|
$1.68B 1.83B USD | $1.04K 1.13K USD | $7.13 7.8 USD | $7.13 7.8 USD | $1.68B 1.83B USD | 0 | -$0.26 -0.2 USD | |
| PeptiDream PPTDF | $13.75 — |
0
|
$1.78B — | $400 — | $13.75 — | $13.75 — | $1.78B — | 114.58 | $0.12 — | |
| Ambrx Biopharma AMAM | $28 — |
0
|
$1.77B — | $0 — | $0 — | $0 — | $1.77B — | 0 | $0 — | |
| Galapagos GLPGF | $26.2 — |
0
|
$1.73B — | $190 — | $26.2 — | $26.2 — | $1.73B — | 51.37 | $0.51 — | |
| Genus plc GBE.F | $22.6 24.7 USD |
+6.6
|
$1.55B 1.7B USD | $6 6.56 USD | $21.6 23.61 USD | $22.6 24.7 USD | $1.55B 1.7B USD | 38.30 | $0.59 0.64 USD | |
| Kura Oncology, Inc. KUR.F | $19.91 21.76 USD |
+4.02
|
$1.55B 1.7B USD | $50 54.66 USD | $19.91 21.76 USD | $19.91 21.76 USD | $1.55B 1.7B USD | 0 | -$2.01 -2.1 USD | |
| Agios Pharmaceuticals, Inc. AGIO.MX | $397.93 23.56 USD |
0
|
$28.11B 1.66B USD | $0 0 USD | $397.93 23.56 USD | $397.93 23.56 USD | $28.11B 1.66B USD | 0 | -$105.76 -6.2 USD | |
| Morphic Holding, Inc. 31Y.F | $27.2 29.73 USD |
+7.09
|
$1.5B 1.64B USD | $228 249.23 USD | $27 29.51 USD | $27.2 29.73 USD | $1.5B 1.64B USD | 0 | -$3.33 -3.6 USD | |
| Ligand Pharmaceuticals Incorporated LGDN.F | $78.5 85.81 USD |
-0.63
|
$1.42B 1.55B USD | $1 1.09 USD | $78.5 85.81 USD | $78.5 85.81 USD | $1.42B 1.55B USD | 15.85 | $4.95 5.41 USD | |
| Genus GENSF | $23.25 — |
-16.99
|
$1.54B — | $2.91K — | $23.25 — | $23.25 — | $1.54B — | 36.32 | $0.64 — | |
| Akero Therapeutics, Inc. 0K4.F | $19.28 21.08 USD |
+3.27
|
$1.39B 1.52B USD | $50 54.66 USD | $19.28 21.08 USD | $19.28 21.08 USD | $1.39B 1.52B USD | 0 | -$3 -3.2 USD | |
| Biotest Aktiengesellschaft BIO3.F | $27.8 30.39 USD |
+1.46
|
$1.39B 1.52B USD | $20 21.86 USD | $27.4 29.95 USD | $27.8 30.39 USD | $1.39B 1.52B USD | 8.68 | $3.2 3.5 USD | |
| Biotest Aktiengesellschaft BIO3.DE | $27.7 30.28 USD |
+0.36
|
$1.37B 1.5B USD | $1 1.09 USD | $27.7 30.28 USD | $27.7 30.28 USD | $1.37B 1.5B USD | 8.65 | $3.2 3.5 USD | |
| Biotest Aktiengesellschaft BIO.DE | $41.6 45.47 USD |
0
|
$1.37B 1.5B USD | $100 109.31 USD | $41.6 45.47 USD | $41.6 45.47 USD | $1.37B 1.5B USD | 12.99 | $3.2 3.5 USD | |
|
Không có cổ phiếu ưa thích
Bạn chưa có cổ phiếu ưa thích nào, hãy thêm nó vào mục ưa thích để thấy nó tại đây |
||||||||||